The analyst's focus is Acadia, so this would be estimated peak sales of trofinetide in Rett syndrome in North America.
The analyst's focus is Acadia, so this would be estimated peak...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.10 |
Change
-0.620(2.99%) |
Mkt cap ! $2.570B | |||
| Open | High | Low | Value | Volume |
| $20.41 | $20.45 | $20.02 | $1.038M | 51.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30 | $20.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.11 | 251 | 5 |
View Market Depth
| Last trade - 11.07am 25/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |